News & Press

CordenPharma Wins 2020 CMO Leadership Awards

March 2, 2020
Press Release > CordenPharma Wins Life Science Leader 2020 CMO Leadership Awards for Expertise, Quality & Service

Press Release > CordenPharma Wins Life Science Leader 2020 CMO Leadership Awards for Expertise, Quality & Service


CordenPharma Wins 2020 Life Science Leader Awards for Expertise, Quality & Service

CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO), is pleased to announce their selection for Life Science Leader 2020 CMO Leadership Awards in three Categories: Expertise, Quality, and Service.

Survey participants were recruited from Pharma and Biopharma companies of all sizes and were screened for decision-making influence related to working with contract manufacturing suppliers. Respondents only evaluated companies with which they worked on an outsourced project within the past 18 months. This level of qualification ensured that survey responses were based on actual involvement with contract manufacturers, with clear experiential data.

Dr. Michael Quirmbach, CEO & President of CordenPharma said, “We are pleased to receive the Life Science Leader 2020 CMO Leadership Awards for Expertise, Quality & Service. These awards from our customers reflect our ongoing efforts to be guided by four pillars that form the foundation of our mission: Customer Centricity & Service, Operational Excellence, Collaborative Partnership, and People & Culture. They remind us to be inspired by the direct impact our customers have on patients, and as such we strive for excellence every day to deliver on-time, high quality products with integrity, transparency and flexibility.”

The 2020 Life Science Leader CMO Leadership Awards ceremony and reception will be held on Wednesday, March 25, 2020 at Convene, 237 Park Ave, New York, NY. Winning CMOs and companies who employ outsourcing services are invited to attend.

About CordenPharma

CordenPharma, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is a full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products, and associated Packaging Services. Through a growing network of cGMP facilities across Europe and the US organized under four Technology Platforms – Peptides, Lipids & Carbohydrates – Injectables – Highly Potent & Oncology – Small Molecules – CordenPharma experts translate complex ideas, processes, and projects at any stage of development into high-value products. For Inquiries: cordenpharma.com/contact-us/.

Read Full Press Release Here